POST Online Media Lite Edition


FiatLux Imaging: Max Lyon new CEO

Staff writer |
Redmond, Wa., USA - March 15, 2010, Redmond, Wa., USA - FiatLux Imaging, a technology company, announced that Max Lyon has joined the company as chief executive officer.

Mr. Lyon has had a successful 25-year career in the medical technology field including experience in both the emerging medical imaging software and internet-based medical services fields.

Mr. Lyon has been CEO/President of six successful medical companies, five of which he co-founded, including BioControl Systems, Bainbridge Sciences (Bard Diagnostics), CG Therapeutics Adeona Pharmaceuticals, NexCura and Confirma.

Mr. Lyon co-founded and led the acquisition of Bainbridge Sciences by C.R. Bard and continued as the President of Bard Diagnostics, and a senior executive team member of C.R. Bard, for four years. He also served as Senior Vice President of Administration at Genetic Systems and was a co-founder and Director of Oncogen, a joint venture of Syntex Corporation and Genetic Systems.

While CEO of Confirma, Mr. Lyon led the development and international commercial launch of the market leading CADstream software-based service for cancer detection using magnetic resonance imaging (MRI).


What to read next

Northrop Grumman names corporate lead executive for Hampton, Virginia
Kaman appoints Michael J. Lyon vice president
Intrinsic Imaging appoints Amy Zastawney as vice president